480 related articles for article (PubMed ID: 23597704)
1. Destabilization of CDC6 upon DNA damage is dependent on neddylation but independent of Cullin E3 ligases.
Tan CY; Hagen T
Int J Biochem Cell Biol; 2013 Jul; 45(7):1489-98. PubMed ID: 23597704
[TBL] [Abstract][Full Text] [Related]
2. Neddylation inhibitor MLN4924 suppresses growth and migration of human gastric cancer cells.
Lan H; Tang Z; Jin H; Sun Y
Sci Rep; 2016 Apr; 6():24218. PubMed ID: 27063292
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of NEDD8-activating enzyme induces rereplication and apoptosis in human tumor cells consistent with deregulating CDT1 turnover.
Milhollen MA; Narayanan U; Soucy TA; Veiby PO; Smith PG; Amidon B
Cancer Res; 2011 Apr; 71(8):3042-51. PubMed ID: 21487042
[TBL] [Abstract][Full Text] [Related]
4. Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage.
Hall JR; Kow E; Nevis KR; Lu CK; Luce KS; Zhong Q; Cook JG
Mol Biol Cell; 2007 Sep; 18(9):3340-50. PubMed ID: 17567951
[TBL] [Abstract][Full Text] [Related]
5. Characterization of cullin-based E3 ubiquitin ligases in intact mammalian cells--evidence for cullin dimerization.
Chew EH; Poobalasingam T; Hawkey CJ; Hagen T
Cell Signal; 2007 May; 19(5):1071-80. PubMed ID: 17254749
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the Cullin (CUL)-RING E3 ligase by the NEDD8-activating enzyme inhibitor MLN4924 triggers protective autophagy in cancer cells.
Luo Z; Pan Y; Jeong LS; Liu J; Jia L
Autophagy; 2012 Nov; 8(11):1677-9. PubMed ID: 22874562
[TBL] [Abstract][Full Text] [Related]
7. Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.
Hua W; Li C; Yang Z; Li L; Jiang Y; Yu G; Zhu W; Liu Z; Duan S; Chu Y; Yang M; Zhang Y; Mao Y; Jia L
Neuro Oncol; 2015 Oct; 17(10):1333-43. PubMed ID: 25904638
[TBL] [Abstract][Full Text] [Related]
8. CBS9106-induced CRM1 degradation is mediated by cullin ring ligase activity and the neddylation pathway.
Saito N; Sakakibara K; Sato T; Friedman JM; Kufe DW; VonHoff DD; Kawabe T
Mol Cancer Ther; 2014 Dec; 13(12):3013-23. PubMed ID: 25253782
[TBL] [Abstract][Full Text] [Related]
9. NEDD8-targeting drug MLN4924 elicits DNA rereplication by stabilizing Cdt1 in S phase, triggering checkpoint activation, apoptosis, and senescence in cancer cells.
Lin JJ; Milhollen MA; Smith PG; Narayanan U; Dutta A
Cancer Res; 2010 Dec; 70(24):10310-20. PubMed ID: 21159650
[TBL] [Abstract][Full Text] [Related]
10. Characterization of MRFAP1 turnover and interactions downstream of the NEDD8 pathway.
Larance M; Kirkwood KJ; Xirodimas DP; Lundberg E; Uhlen M; Lamond AI
Mol Cell Proteomics; 2012 Mar; 11(3):M111.014407. PubMed ID: 22038470
[TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor angiogenesis by targeting the protein neddylation pathway.
Yao WT; Wu JF; Yu GY; Wang R; Wang K; Li LH; Chen P; Jiang YN; Cheng H; Lee HW; Yu J; Qi H; Yu XJ; Wang P; Chu YW; Yang M; Hua ZC; Ying HQ; Hoffman RM; Jeong LS; Jia LJ
Cell Death Dis; 2014 Feb; 5(2):e1059. PubMed ID: 24525735
[TBL] [Abstract][Full Text] [Related]
12. Targeting protein neddylation with an NEDD8-activating enzyme inhibitor MLN4924 induced apoptosis or senescence in human lymphoma cells.
Wang Y; Luo Z; Pan Y; Wang W; Zhou X; Jeong LS; Chu Y; Liu J; Jia L
Cancer Biol Ther; 2015; 16(3):420-9. PubMed ID: 25782162
[TBL] [Abstract][Full Text] [Related]
13. Regulation of neddylation and deneddylation of cullin1 in SCFSkp2 ubiquitin ligase by F-box protein and substrate.
Bornstein G; Ganoth D; Hershko A
Proc Natl Acad Sci U S A; 2006 Aug; 103(31):11515-20. PubMed ID: 16861300
[TBL] [Abstract][Full Text] [Related]
14. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
Zhao Y; Morgan MA; Sun Y
Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
[TBL] [Abstract][Full Text] [Related]
15. Novel DNA damage checkpoints mediating cell death induced by the NEDD8-activating enzyme inhibitor MLN4924.
Blank JL; Liu XJ; Cosmopoulos K; Bouck DC; Garcia K; Bernard H; Tayber O; Hather G; Liu R; Narayanan U; Milhollen MA; Lightcap ES
Cancer Res; 2013 Jan; 73(1):225-34. PubMed ID: 23100467
[TBL] [Abstract][Full Text] [Related]
16. Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization.
Chen C; Gu L; Matye DJ; Clayton YD; Hasan MN; Wang Y; Friedman JE; Li T
Proc Natl Acad Sci U S A; 2022 Feb; 119(6):. PubMed ID: 35115401
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin promotes cancer radiosensitization through Cullin1 neddylation-mediated CDC6 protein degradation.
Deng T; Zhu Q; Xie L; Liu Y; Peng Y; Yin L; Gao Y; Cao T; Fu Y; Qi X; Zhang S; Peng Y; Hou Y; Li X
Mol Carcinog; 2022 Aug; 61(8):812-824. PubMed ID: 35652616
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1.
Petersen BO; Wagener C; Marinoni F; Kramer ER; Melixetian M; Lazzerini Denchi E; Gieffers C; Matteucci C; Peters JM; Helin K
Genes Dev; 2000 Sep; 14(18):2330-43. PubMed ID: 10995389
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and cellular effects of inhibiting Nedd8 conjugation.
Leck YC; Choo YY; Tan CY; Smith PG; Hagen T
Biochem Biophys Res Commun; 2010 Jul; 398(3):588-93. PubMed ID: 20603103
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin E3 ligase CRL4(CDT2/DCAF2) as a potential chemotherapeutic target for ovarian surface epithelial cancer.
Pan WW; Zhou JJ; Yu C; Xu Y; Guo LJ; Zhang HY; Zhou D; Song FZ; Fan HY
J Biol Chem; 2013 Oct; 288(41):29680-91. PubMed ID: 23995842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
